MBF Therapeutics

About:

MBF Therapeutics advances the standard of cancer care for companion animals by developing innovative products.

Top Investors: National Science Foundation, Ben Franklin Technology Partners of Southeastern Pennsylvania, Ben Franklin Technology Partners, StartUp PHL

Description:

MBF Therapeutics is a clinical-stage animal health company focusing on the development of gene-based, immunotherapeutic vaccines for use in veterinary medicine. Using proprietary vaccine platform and delivery system technology, MBF Therapeutics’ checkpoint inhibitor therapies have the potential of transforming the treatment of cancer and prevention of infectious diseases in companion animals and livestock.

Total Funding Amount:

$851000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Ambler, Pennsylvania, United States

Founded Date:

2008-01-01

Contact Email:

Info(AT)mbftherapeutics.com

Founders:

Lorraine Keller, Thomas C. Tillett

Number of Employees:

1-10

Last Funding Date:

2021-12-21

IPO Status:

Private

Industries: